THE DEAL, AT A GLANCE
From the announcementLiflex
Medicine development What it doesOverview Liflex Science is a South Korean biotechnology company developing RNA-based therapeutics for degenerative arthritis and other musculoskeletal disease…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Who is involvedBacked by Jin-Hong Kim, Dong-Soon Ahn (From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedLiflex raised $5.3M Series A, announced 2026-11-13From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersLiflex raised a $5.25M Series A in a financing tracked as Unclassified.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Liflex · Financing Record
Explore source-linked visual explanations for Liflex. Unsupported claims are withheld while source review continues.
Record 15944 · Recorded date: 2026-11-13
Explore company records →